Cargando…

A Study of Antidepressant Effect and Mechanism on Intranasal Delivery of BDNF-HA2TAT/AAV to Rats with Post-Stroke Depression

AIM: Post-stroke depression (PSD) is one of the most frequent neuropsychiatric disorders associated with stroke characterized by depression. The neuroplasticity hypothesis postulates that loss of brain-derived neurotrophic factor (BDNF) plays a major role in pathophysiology of PSD, and restoration o...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ce, Dong, Yingying, Liu, Fei, Gao, Chengge, Ji, Cui, Dang, Yonghui, Ma, Xiancang, Liu, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061423/
https://www.ncbi.nlm.nih.gov/pubmed/32184603
http://dx.doi.org/10.2147/NDT.S227598
_version_ 1783504386588147712
author Chen, Ce
Dong, Yingying
Liu, Fei
Gao, Chengge
Ji, Cui
Dang, Yonghui
Ma, Xiancang
Liu, Yong
author_facet Chen, Ce
Dong, Yingying
Liu, Fei
Gao, Chengge
Ji, Cui
Dang, Yonghui
Ma, Xiancang
Liu, Yong
author_sort Chen, Ce
collection PubMed
description AIM: Post-stroke depression (PSD) is one of the most frequent neuropsychiatric disorders associated with stroke characterized by depression. The neuroplasticity hypothesis postulates that loss of brain-derived neurotrophic factor (BDNF) plays a major role in pathophysiology of PSD, and restoration of it may represent a critical mechanism underlying antidepressant efficacy. METHODS: In previous studies, we designed a new fusion gene, HA2TAT-BDNF, and cloned it into adenovirus associated virus (AAV) to construct the BDNF-HA2TAT/AAV for the delivery of BDNF to central nervous system (CNS) via nose-brain pathway. In this study, we used it to explore the antidepressant effects on PSD rats through behavioral and various histological methods, and try to find out its specific mechanism. RESULTS: Compared with the control group, the PSD+AAV group showed decreased sucrose consumption percentage in the sucrose preference test (SPT) (P < 0.001) and prolonged immobility in the forced swimming test (FST) (P=0.000). However, the nasal administration of BDNF-HA2TAT/AAV reversed results of these two behavioral tests (P>0.05, P >0.05), showing an adequate antidepressant effect. Compared with the control group, the concentrations of BDNF mRNA and protein in the hippocampus (P< 0.05, P < 0.01) and prefrontal cortex (P < 0.01, P < 0.01) of PSD rats both decreased. Increased BDNF mRNA and protein expression was observed in the prefrontal cortex (P > 0.05, P < 0.05), without notable change in the hippocampus (P < 0.05, P < 0.001) of PSD+BDNF rats. CONCLUSION: These results suggest that BDNF reductions in the prefrontal cortex and hippocampus are associated with the development of post-stroke depression, and that increased levels of BDNF in the prefrontal cortex could be used as a therapeutic target to treat PSD. However, the exact mechanism of BDNF action remains unclear in this regard, hindering the wider application of our method. We expect that our research could facilitate the exploration of pathogenesis and the new treatment method of PSD.
format Online
Article
Text
id pubmed-7061423
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-70614232020-03-17 A Study of Antidepressant Effect and Mechanism on Intranasal Delivery of BDNF-HA2TAT/AAV to Rats with Post-Stroke Depression Chen, Ce Dong, Yingying Liu, Fei Gao, Chengge Ji, Cui Dang, Yonghui Ma, Xiancang Liu, Yong Neuropsychiatr Dis Treat Original Research AIM: Post-stroke depression (PSD) is one of the most frequent neuropsychiatric disorders associated with stroke characterized by depression. The neuroplasticity hypothesis postulates that loss of brain-derived neurotrophic factor (BDNF) plays a major role in pathophysiology of PSD, and restoration of it may represent a critical mechanism underlying antidepressant efficacy. METHODS: In previous studies, we designed a new fusion gene, HA2TAT-BDNF, and cloned it into adenovirus associated virus (AAV) to construct the BDNF-HA2TAT/AAV for the delivery of BDNF to central nervous system (CNS) via nose-brain pathway. In this study, we used it to explore the antidepressant effects on PSD rats through behavioral and various histological methods, and try to find out its specific mechanism. RESULTS: Compared with the control group, the PSD+AAV group showed decreased sucrose consumption percentage in the sucrose preference test (SPT) (P < 0.001) and prolonged immobility in the forced swimming test (FST) (P=0.000). However, the nasal administration of BDNF-HA2TAT/AAV reversed results of these two behavioral tests (P>0.05, P >0.05), showing an adequate antidepressant effect. Compared with the control group, the concentrations of BDNF mRNA and protein in the hippocampus (P< 0.05, P < 0.01) and prefrontal cortex (P < 0.01, P < 0.01) of PSD rats both decreased. Increased BDNF mRNA and protein expression was observed in the prefrontal cortex (P > 0.05, P < 0.05), without notable change in the hippocampus (P < 0.05, P < 0.001) of PSD+BDNF rats. CONCLUSION: These results suggest that BDNF reductions in the prefrontal cortex and hippocampus are associated with the development of post-stroke depression, and that increased levels of BDNF in the prefrontal cortex could be used as a therapeutic target to treat PSD. However, the exact mechanism of BDNF action remains unclear in this regard, hindering the wider application of our method. We expect that our research could facilitate the exploration of pathogenesis and the new treatment method of PSD. Dove 2020-03-04 /pmc/articles/PMC7061423/ /pubmed/32184603 http://dx.doi.org/10.2147/NDT.S227598 Text en © 2020 Chen et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Chen, Ce
Dong, Yingying
Liu, Fei
Gao, Chengge
Ji, Cui
Dang, Yonghui
Ma, Xiancang
Liu, Yong
A Study of Antidepressant Effect and Mechanism on Intranasal Delivery of BDNF-HA2TAT/AAV to Rats with Post-Stroke Depression
title A Study of Antidepressant Effect and Mechanism on Intranasal Delivery of BDNF-HA2TAT/AAV to Rats with Post-Stroke Depression
title_full A Study of Antidepressant Effect and Mechanism on Intranasal Delivery of BDNF-HA2TAT/AAV to Rats with Post-Stroke Depression
title_fullStr A Study of Antidepressant Effect and Mechanism on Intranasal Delivery of BDNF-HA2TAT/AAV to Rats with Post-Stroke Depression
title_full_unstemmed A Study of Antidepressant Effect and Mechanism on Intranasal Delivery of BDNF-HA2TAT/AAV to Rats with Post-Stroke Depression
title_short A Study of Antidepressant Effect and Mechanism on Intranasal Delivery of BDNF-HA2TAT/AAV to Rats with Post-Stroke Depression
title_sort study of antidepressant effect and mechanism on intranasal delivery of bdnf-ha2tat/aav to rats with post-stroke depression
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061423/
https://www.ncbi.nlm.nih.gov/pubmed/32184603
http://dx.doi.org/10.2147/NDT.S227598
work_keys_str_mv AT chence astudyofantidepressanteffectandmechanismonintranasaldeliveryofbdnfha2tataavtoratswithpoststrokedepression
AT dongyingying astudyofantidepressanteffectandmechanismonintranasaldeliveryofbdnfha2tataavtoratswithpoststrokedepression
AT liufei astudyofantidepressanteffectandmechanismonintranasaldeliveryofbdnfha2tataavtoratswithpoststrokedepression
AT gaochengge astudyofantidepressanteffectandmechanismonintranasaldeliveryofbdnfha2tataavtoratswithpoststrokedepression
AT jicui astudyofantidepressanteffectandmechanismonintranasaldeliveryofbdnfha2tataavtoratswithpoststrokedepression
AT dangyonghui astudyofantidepressanteffectandmechanismonintranasaldeliveryofbdnfha2tataavtoratswithpoststrokedepression
AT maxiancang astudyofantidepressanteffectandmechanismonintranasaldeliveryofbdnfha2tataavtoratswithpoststrokedepression
AT liuyong astudyofantidepressanteffectandmechanismonintranasaldeliveryofbdnfha2tataavtoratswithpoststrokedepression
AT chence studyofantidepressanteffectandmechanismonintranasaldeliveryofbdnfha2tataavtoratswithpoststrokedepression
AT dongyingying studyofantidepressanteffectandmechanismonintranasaldeliveryofbdnfha2tataavtoratswithpoststrokedepression
AT liufei studyofantidepressanteffectandmechanismonintranasaldeliveryofbdnfha2tataavtoratswithpoststrokedepression
AT gaochengge studyofantidepressanteffectandmechanismonintranasaldeliveryofbdnfha2tataavtoratswithpoststrokedepression
AT jicui studyofantidepressanteffectandmechanismonintranasaldeliveryofbdnfha2tataavtoratswithpoststrokedepression
AT dangyonghui studyofantidepressanteffectandmechanismonintranasaldeliveryofbdnfha2tataavtoratswithpoststrokedepression
AT maxiancang studyofantidepressanteffectandmechanismonintranasaldeliveryofbdnfha2tataavtoratswithpoststrokedepression
AT liuyong studyofantidepressanteffectandmechanismonintranasaldeliveryofbdnfha2tataavtoratswithpoststrokedepression